Popular Articles

Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data For AM211, A Novel Product Candidate For The Treatment Of Respiratory Diseases
Amira Pharmaceuticals, Inc. announced initial positive data from a Phase 1 clinical study of AM211, the company"s oral selective antagonist of the DP2 (also known as CRTH2) receptor.
buy viagra
Tesco Reveals Dental Map Of Britain
Research from a survey by Tesco Dental Insurance has revealed Brits are finding it increasingly difficulty to find an NHS dentist. The results also show that rising dental costs are putting people off visiting the dentist.
plan for health
News of the day
Secretary Sebelius Releases Inaugural Health Care "Success Story" Report
HHS Secretary Kathleen Sebelius released the first in a series of health care "success story" reports that document innovative programs and initiatives that can serve as models for a reformed American health care system. The inaugural report highlights the Michigan Keystone ICU Project. A joint partnership between the Michigan Health & Hospital Association and the Johns Hopkins University, the Michigan Keystone ICU Project helped dramatically reduce the number of health care associated infections in Michigan, saving over 1,500 lives and $200 million.
Cardiovascular

Forecasting Cancer Recurrence

Two people with the same kind of cancer who receive the exact same treatment may nevertheless have different chances of their tumors coming back years later. Now a team of scientists has developed a computer model that predicts cancer recurrence in an individual based on how her tumor changes size in response to the first rounds of radiation therapy. The team, headed by Jian Z. Wang, director of the Radiation Response Modeling Program at the James Cancer Hospital and Solove Research Institute of Ohio State University in Columbus, will present the findings at the 51st Annual Meeting of the American Association of Physicists in Medicine (AAPM) in Anaheim, California. The leading author, Zhibin Huang, has been selected as this meeting"s winner of the Jack Fowler Junior Investigator"s Competition. Huang and colleagues at Ohio State University studied 80 women with cervical cancer who were diagnosed with tumors ranging from the size of a marble to the size of a grapefruit. Each woman was treated with a course of radiation therapy -- beams of energy that destroyed the cancerous cells in her pelvis. After few weeks of radiation treatment, the volume of each shrinking tumor was measured using an MRI scanner. By fitting a mathematical model to this data, Huang calculated two things important for understanding how the tumors were responding to the radiotherapy: the fraction of cancerous cells that survived each of the daily radiation treatments and the amount of time it took each woman"s body to clear away and flush out those cells that were destroyed. The two properties vary from individual to individual and from tumor to tumor. These numbers could be used to predict whether or not a woman"s cervical cancer would come back years after her treatments. If each daily radiation treatment annihilated at least 70 percent of a tumor, a woman had a 30 percent better chance of avoiding recurrence than an individual with a more resistant tumor. Similarly, women whose bodies took longer than 22 days to clear out dead cells after each treatment were almost twice as likely to see their tumors reappear down the road. The results, presented at this year"s AAPM meeting, suggest that not all cervical cancers are the same. To improve treatment, said Wang, patients should be grouped based on whether their tumors are radioresistant or radiosensitive. Other kinds of cancer could also benefit from this approach, says Nina A. Mayr, a professor of radiation oncology at the Ohio State University James Cancer Hospital and Solove Research Institute. "Using similar techniques, ongoing projects from our group are tackling other cancer sites, such as lung and prostate cancer." ABOUT MEDICAL PHYSICISTS If you ever had a mammogram, ultrasound, X-ray, MRI, PET scan, or known someone treated for cancer, chances are reasonable that a medical physicist was working behind the scenes to make sure the imaging procedure was as effective as possible. Medical physicists help to develop new imaging techniques, improve existing ones, and assure the safety of radiation used in medical procedures in radiology, radiation oncology and nuclear medicine. They collaborate with radiation oncologists to design cancer treatment plans. They provide routine quality assurance and quality control on radiation equipment and procedures to ensure that cancer patients receive the prescribed dose of radiation to the correct location. They also contribute to the development of physics intensive therapeutic techniques, such as the stereotactic radiosurgery and prostate seed implants for cancer to name a few. The annual AAPM meeting is a great re, providing guidance to physicists to implement the latest and greatest technology in a community hospital close to you. ABOUT AAPM The American Association of Physicists in Medicine (AAPM) is a scientific, educational, and professional organization of more than 6,000 medical physicists. Headquarters are located at the American Center for Physics in College Park, MD. Publications include a scientific journal ("Medical Physics"), technical reports, and symposium proceedings. American Institute of Physics (AIP)


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):